SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) TREATMENT EVALUATION OF ADULT PATIENTS WITH SLE

https://doi.org/10.22146/jmpf.80

Nancy Nancy(1*), Zullies Ikawati(2)

(1) Magister Manajemen Farmasi Universitas Gadjah Mada
(2) Fakultas Farmasi Universitas Gadjah Mada
(*) Corresponding Author

Abstract


Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by fluctuating disease activity. SLE treatment in Indonesia is still limited on how to control clinical features and complications that may occur, using glucocorticoids, NSAIDS, antimalarial agents, and cytotoxic drugs. The objectives of this study were to identify treatment patterns and the degree of appropriate treatment among SLE patients. A retrospective study was carried out using medical record data of adult patients with SLE diagnoses in the inpatient department of X Public Hospital Yogyakarta during January-December 2011. Appropriate descriptive analysis was used. The results showed that the most used drugs in SLE pharmacologic therapy were topical antiinflammatory agents 56%, glucocorticoid methylprednisolone 47%, cytotoxic mycophenolate mofetil 17%, antimalarial chloroquine 9%, and NSAID diclofenac sodium 6% while the most common treatment pattern was with glucocorticoid as monotherapy (35%). The degree of appropriate indication, patient, drug, and dosage were 100%, 100%, 53%, and 83% respectively.

Keywords : Treatment Evaluation, Systemic Lupus Erythematosus (SLE), Hospital


Full Text:

Untitled



DOI: https://doi.org/10.22146/jmpf.80

Article Metrics

Abstract views : 3810 | views : 15809

Refbacks

  • There are currently no refbacks.


Copyright (c) 1970 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats